Phenetyl-thiourea compounds for treating hiv infections

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 213/75 (2006.01) A61K 31/44 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2375342

Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.

Nouveaux composés de phényléthyl-thiourée (PHET) en tant qu'inhibiteurs de la transcriptase inverse et agents efficaces pour le traitement de l'infection due au VIH, y compris les souches de VIH mutantes, sensibles aux médicaments, résistantes aux médicaments et multirésistantes aux médicaments.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Phenetyl-thiourea compounds for treating hiv infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenetyl-thiourea compounds for treating hiv infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenetyl-thiourea compounds for treating hiv infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1937621

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.